Detection of Enterovirus Genotypes by CRISPR Technology
NCT04535648 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-06-09
Summary
CRISPR-enterovirus detection system was constructed in this study for detection variety genotypes of enterovirus rapidly in children suspected or diagnosed as enterovirus infection.
Conditions
- Enterovirus Infections
Interventions
- OTHER
-
Non-invasive detection method: CRISPR techonology
This study was a laboratory diagnostic study without any intervention.
Sponsors & Collaborators
-
Children's Hospital of Fudan University
lead OTHER
Principal Investigators
-
Liling Qian · Children's Hospital of Fudan University
Eligibility
- Min Age
- 1 Day
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-30
- Primary Completion
- 2024-08-31
- Completion
- 2024-09-30
More Related Trials
-
Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)
NCT00130832 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)
NCT00953056 ·Status: COMPLETED ·Phase: PHASE1
-
Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™
NCT01511133 ·Status: COMPLETED
-
Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)
NCT04563533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
NCT06592794 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers
NCT05626803 ·Status: COMPLETED ·Phase: PHASE2
-
Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine
NCT01738074 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants
NCT00757926 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
V260 Registration Study (V260-013)(COMPLETED)
NCT00166517 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure
NCT00995813 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine
NCT02868073 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine
NCT03865238 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
NCT02133690 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population
NCT06011200 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
NCT00262028 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children
NCT05099029 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years
NCT05156528 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase II Clinical Trial of the Inactivated Rotavirus Vaccine
NCT06080906 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers
NCT00626327 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety of Rotarix™ in Chinese Children
NCT01086436 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
NCT01061658 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children
NCT02556996 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections
NCT05766904 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
NCT00329745 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants
NCT04825223 ·Status: TERMINATED ·Phase: PHASE1